HIFs (Hypoxia-inducible factors) are transcription factors that respond to changes in available oxygen in the cellular environment, to be specific, to decreases in oxygen, or hypoxia. The HIF signaling cascade mediates the effects of hypoxia, the state of low oxygen concentration, on the cell. Hypoxia often keeps cells from differentiating. However, hypoxia promotes the formation of blood vessels, and is important for the formation of a vascular system in embryos, and cancer tumors. The hypoxia in wounds also promotes the migration of keratinocytes and the restoration of the epithelium. In general, HIFs are vital to development. In mammals, deletion of the HIF-1 genes results in perinatal death. HIF-1 has been shown to be vital to chondrocyte survival, allowing the cells to adapt to low-oxygen conditions within the growth plates of bones. HIF plays a central role in the regulation of human metabolism. Recently, several drugs that act as selective HIF prolyl-hydroxylase inhibitors have been developed.
THS-044 是 HIF2α/ARNT 异二聚体形成的调节剂,其结合可稳定 HIF2α PAS-B 的折叠状态(KD = 2 μM),从而在内源及病理环境中调控 HIF2 的活性,且不与 HIF1α 或 ARNT PAS-B 结合,可用于研究与缺氧相关的疾病。
VU 0364439 是一种 EC50 为 19.8 nM 的 mGlu4 阳性变构调节剂,通过增强 GRM4-CBX4 相互作用调控 GRM4/CBX4/HIF-1α 信号通路,可用于帕金森病的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号